Zoetis Inc. $ZTS Position Trimmed by Aberdeen Group plc

Aberdeen Group plc decreased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 89.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 95,470 shares of the company’s stock after selling 824,353 shares during the quarter. Aberdeen Group plc’s holdings in Zoetis were worth $6,667,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of ZTS. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Zoetis during the 2nd quarter valued at $25,000. Dunhill Financial LLC grew its holdings in shares of Zoetis by 519.3% in the 2nd quarter. Dunhill Financial LLC now owns 353 shares of the company’s stock worth $25,000 after acquiring an additional 296 shares during the last quarter. Cassaday & Co Wealth Management LLC acquired a new position in shares of Zoetis in the 1st quarter worth $28,000. First Command Advisory Services Inc. grew its holdings in shares of Zoetis by 3,881.8% in the 3rd quarter. First Command Advisory Services Inc. now owns 438 shares of the company’s stock worth $31,000 after acquiring an additional 427 shares during the last quarter. Finally, Wellington Grp LLC raised its position in shares of Zoetis by 6,675.0% during the first quarter. Wellington Grp LLC now owns 271 shares of the company’s stock worth $32,000 after purchasing an additional 267 shares during the period. Institutional investors own 92.80% of the company’s stock.

More Zoetis News

Investors following ZTS have been watching these news items:

Analysts Set New Price Targets

ZTS has been the subject of several analyst reports. Stifel Nicolaus reduced their target price on Zoetis from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, August 20th. Jefferies Financial Group raised their target price on shares of Zoetis from $83.00 to $85.00 in a report on Friday, November 6th. BTIG Research dropped coverage on shares of Zoetis in a research report on Friday, October 30th. They issued a “buy” rating and a $200.00 target price on the stock. BNP Paribas Exane cut their price target on shares of Zoetis from $146.00 to $110.00 and set an “outperform” rating on the stock in a report on Tuesday, August 11th. Finally, Morgan Stanley reduced their price target on shares of Zoetis from $85.00 to $82.00 and set an “overweight” rating for the company in a research report on Thursday, October 29th. Eight equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Zoetis has an average rating of “Hold” and a consensus target price of $101.25.

View Our Latest Research Report on ZTS

Zoetis Trading Down 5.5%

Shares of NYSE:ZTS opened at $80.85 on Friday. The company has a debt-to-equity ratio of 2.51, a quick ratio of 1.40 and a current ratio of 2.35. The stock’s 50-day moving average is $77.04 and its 200-day moving average is $90.76. The company has a market cap of $32.85 billion, a P/E ratio of 13.75, a P/E/G ratio of 1.24 and a beta of 0.67. Zoetis Inc. has a 52-week low of $68.77 and a 52-week high of $132.49.

Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.24. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.30 billion. Zoetis had a return on equity of 85.90% and a net margin of 26.15%. Zoetis’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.70 earnings per share. Equities research analysts predict that Zoetis Inc. will post 6.29 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 30th. Zoetis’s payout ratio is 36.05%.

About Zoetis

(Free Report)

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.

Featured Articles

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.